PLEASANTON, CA -- (Marketwired) -- 08/06/14 -- ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced it is exhibiting at the summer meeting of the American Academy of Dermatology (AAD) in Chicago, August 6-10, 2014. ZELTIQ is the developer of the non-surgical, clinically proven CoolSculpting® procedure which selectively reduces fat in treated areas using a patented cooling technology.
The company will showcase its CoolSmooth applicator, the first and only non-surgical solution clinically proven and designed for fat reduction of the outer thighs. Combining the CoolSmooth applicator with the CoolFit applicator, launched last year and designed to treat the inner thigh, the CoolSculpting procedure can now treat the complete thigh. The procedure is cleared by the FDA to treat the abdomen, flank and thigh.
For the complete summer AAD program, visit www.aad.org. For information about CoolSculpting, visit ZELTIQ at Booth #1512.
WHAT: CoolSculpting Procedure
ZELTIQ Booth #1512
WHEN: Summer AAD Exhibit Hours
Friday, August 8, 2014, 10:00 a.m. - 6:00 p.m.
Saturday, August 9, 2014, 10:00 a.m. - 5:00 p.m.
WHERE: American Academy of Dermatology (AAD) Summer Meeting
Hyatt Regency Chicago
151 East Upper Wacker Drive
Chicago, IL 60601
About ZELTIQ® Aesthetics, Inc.
ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting system, is designed to selectively reduce stubborn fat that may not respond to diet or exercise. The CoolSculpting procedure is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed the CoolSculpting procedure to safely, noticeably, and measurably reduce the fat layer.